ZITHROMAX is supplied in the following strengths and package configurations:
| Tablet strength | Tablet Color/Shape | Tablet Markings | Package Size | NDC Code |
|---|---|---|---|---|
250 mg | Pink modified capsular shaped, engraved, film-coated | Engraved with "PFIZER" on one side and "306" on the other | Bottles of 30 | NDC 0069-3060-30 |
Boxes of 3 (Z-PAKS of 6) | NDC 0069-3060-75 | |||
Unit Dose package of 50 | NDC 0069-3060-86 | |||
Engraved with "Pfizer" on one side and "ZTM 250" on the other | Bottles of 30 | NDC 0069-4061-01 | ||
Boxes of 3 (Z-PAKS of 6) | NDC 0069-4061-75 | |||
Unit Dose package of 50 | NDC 0069-4061-89 | |||
500 mg | Pink modified capsular shaped, engraved, film coated | Engraved with "Pfizer" on one side and "ZTM500" on the other | Bottles of 30 | NDC 0069-3070-30 |
Boxes of 3 (TRI-PAKS™ of 3 tablets) | NDC 0069-3070-75 |
ZITHROMAX tablets should be stored between 15° to 30°C (59° to 86°F).
ZITHROMAX for oral suspension after constitution contains a flavored suspension. ZITHROMAX for oral suspension is supplied to provide 100 mg/5 mL or 200 mg/5 mL suspension in bottles as follows:
| Azithromycin contents per bottle | NDC |
|---|---|
300 mg | 0069-3110-19 |
600 mg | 0069-3120-19 |
900 mg | 0069-3130-19 |
1200 mg | 0069-3140-19 |
[see Dosage and Administration (2)] for constitution instructions with each bottle type.
ZITHROMAX is supplied in the following strengths and package configurations:
| Tablet strength | Tablet Color/Shape | Tablet Markings | Package Size | NDC Code |
|---|---|---|---|---|
250 mg | Pink modified capsular shaped, engraved, film-coated | Engraved with "PFIZER" on one side and "306" on the other | Bottles of 30 | NDC 0069-3060-30 |
Boxes of 3 (Z-PAKS of 6) | NDC 0069-3060-75 | |||
Unit Dose package of 50 | NDC 0069-3060-86 | |||
Engraved with "Pfizer" on one side and "ZTM 250" on the other | Bottles of 30 | NDC 0069-4061-01 | ||
Boxes of 3 (Z-PAKS of 6) | NDC 0069-4061-75 | |||
Unit Dose package of 50 | NDC 0069-4061-89 | |||
500 mg | Pink modified capsular shaped, engraved, film coated | Engraved with "Pfizer" on one side and "ZTM500" on the other | Bottles of 30 | NDC 0069-3070-30 |
Boxes of 3 (TRI-PAKS™ of 3 tablets) | NDC 0069-3070-75 |
ZITHROMAX tablets should be stored between 15° to 30°C (59° to 86°F).
ZITHROMAX for oral suspension after constitution contains a flavored suspension. ZITHROMAX for oral suspension is supplied to provide 100 mg/5 mL or 200 mg/5 mL suspension in bottles as follows:
| Azithromycin contents per bottle | NDC |
|---|---|
300 mg | 0069-3110-19 |
600 mg | 0069-3120-19 |
900 mg | 0069-3130-19 |
1200 mg | 0069-3140-19 |
[see Dosage and Administration (2)] for constitution instructions with each bottle type.
{{section_body_html_patient}}
Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine.
*Speak with a Pfizer Medical Information Professional regarding your medical inquiry. Available 9AM-5PM ET Monday to Friday; excluding holidays.
Submit a medical question for Pfizer prescription products.
Pfizer Safety
To report an adverse event related to the Pfizer-BioNTech COVID-19 Vaccine, and you are not part of a clinical trial* for this product, click the link below to submit your information:
Pfizer Safety Reporting Site*If you are involved in a clinical trial for this product, adverse events should be reported to your coordinating study site.
If you cannot use the above website, or would like to report an adverse event related to a different Pfizer product, please call Pfizer Safety at (800) 438-1985.
FDA Medwatch
You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at www.fda.gov/medwatch or call (800) 822-7967.